2,5,8-三甲基喹啉 | 102871-69-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 2,5,8-三甲基喹啉
• 英文名称: 2,5,8-trimethylquinoline
• 英文别名: 2,5,8-Trimethyl-chinolin
• CAS: 102871-69-2
• 化学式: C₁₂H₁₃N
• mdl: MFCD09787532
• 分子量: 171.242
• InChiKey: BAPDDVZQIJZBPQ-UHFFFAOYSA-N

物化性质

• 沸点：
  144-146 °C(Press: 15 Torr)
• 密度：
  1.034±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933499090

反应信息

• 作为反应物：
  描述：

  2,5,8-三甲基喹啉 在 盐酸 、 硫酸 、 potassium nitrate 、 tin(ll) chloride 作用下， 生成 2,5,8-trimethyl-[6]quinolylamine
  参考文献：
  名称：

  The Synthesis and Nitration of 2,6- and 2,7-Dimethylquinoline and of 2,5,8-Trimethylquinoline

  摘要：

  DOI：

  10.1021/ja01113a049
• 作为产物：
  描述：

  2,5-二甲基硝基苯 在 硫酸 、 铁粉 、 溶剂黄146 、 3-硝基苯磺酸水合物 作用下， 生成 2,5,8-三甲基喹啉
  参考文献：
  名称：

  The Synthesis and Nitration of 2,6- and 2,7-Dimethylquinoline and of 2,5,8-Trimethylquinoline

  摘要：

  DOI：

  10.1021/ja01113a049

文献信息

• Synthesis of substituted 2-alkylquinolines by visible-light photoredox catalysis
  作者：Yousheng Mei、Jie Liu、Lei Wang、Pinhua Li

  DOI：10.1039/c9ob02259g

  日期：——

  The condensation of anilines and alkenyl ethers has been demonstrated by employing visible-light photoredox catalysis. The resulting method enables the synthesis of substituted 2-alkylquinolines under mild and simple conditions with good substrate scope and high yields.

  苯胺和烯基醚的缩合已通过可见光光氧化还原催化得到证实。所得方法能够在温和而简单的条件下以良好的底物范围和高收率合成取代的2-烷基喹啉。
• Heterocycle-containing carboxylic acid derivative and drug containing the same
  申请人：Eisai Co. Ltd.

  公开号：US20020032202A1

  公开（公告）日：2002-03-14

  Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): 1 wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR 6 ═CR 7 — in which R 6 and R 7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

  描述了一种含有杂环的羧酸衍生物，其化学式如下（I）：1其中A代表含有至少一个氮原子和可能具有取代基的杂芳基团，B代表例如杂芳烷基团，—CONH—基团或由公式—CR6═CR7—所表示的基团，其中R6和R7代表H、低碳基团或类似物，D代表芳基团、杂芳基团或类似物，n1代表0或1，M代表例如羟基或低碳氧基团；或其生理上可接受的盐。作为替代视黄酸的视黄酸相关化合物，它可以提供预防和/或治疗各种疾病的方法。
• Heterocycl-containing carboxylic acid derivative and drug containing the same
  申请人：Eisai Co. Ltd.

  公开号：US20020103234A1

  公开（公告）日：2002-08-01

  Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): 1 wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a —CONH— group or a group represented by the formula —CR 6 ═CR 7 — in which R 6 and R 7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

  描述了一种含杂环的羧酸衍生物，其化学式为（I）：1，其中A代表例如至少含有一个氮原子并且可能具有取代基的杂芳基团，B代表例如杂芳烃基团，-CONH-基团或由式子-CR6═CR7-表示的基团，其中R6和R7代表H、低碳基或类似物，D代表芳烃基团、杂芳烃基团或类似物，n1代表0或1，M代表例如羟基或低碳氧基基团；或其生理上可接受的盐。作为替代视黄酸的视黄酸相关化合物，它可以提供预防和/或治疗各种疾病的方法。
• NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
  申请人：Girardet Jean-Luc

  公开号：US20080249131A1

  公开（公告）日：2008-10-09

  Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds.

  各种羰基酰胺在体外和体内被用作反转录酶的非核苷类抑制剂，尤其是HIV反转录酶的抑制剂。因此，考虑到的化合物可以用于治疗HIV感染患者。进一步考虑的方面包括包含考虑化合物的治疗有效量的制药组合物。
• Heterocycle-containing carboxylic acid derivative and drug containing
  申请人：Eisai Co., Ltd

  公开号：US05977108A1

  公开（公告）日：1999-11-02

  Described is a heterocycle-containing carboxylic acid derivative represented by the following formula (I): ##STR1## wherein A represents, for example, a heteroaryl group which contains at least one nitrogen atom and may have a substituent, B represents, for example, a heteroarylene group, a --CONH-- group or a group represented by the formula --CR.sup.6 .dbd.CR.sup.7 -- in which R.sup.6 and R.sup.7 represents H, a lower alkyl group or the like, D represents an arylene group, a heteroarylene group or the like, n1 stands for 0 or 1, M represents, for example, a hydroxyl group or a lower alkoxy group; or a physiologically acceptable salt thereof. As a retinoic-related compound replacing retinoic acid, it permits the provision of a preventive and/or therapeutic for various diseases.

  描述了一种含有杂环的羧酸衍生物，其化学式表示为（I）：##STR1## 其中A表示，例如，至少含有一个氮原子并且可能具有取代基的杂芳基团，B表示例如杂芳基烷基团，--CONH--基团或公式--CR.sup.6.dbd.CR.sup.7--所表示的基团，其中R.sup.6和R.sup.7表示H，低碳基团或类似物，D表示芳基团，杂芳基团或类似物，n1代表0或1，M表示例如羟基或低碳基氧基团；或其生理上可接受的盐。作为一种替代视黄酸的视黄酸相关化合物，它可以提供预防和/或治疗各种疾病的方法。